Politicians shouldn’t play God with drugs funding

Politicians shouldn’t play God with drugs funding

Prioritising one patient group - perhaps because of the power of their advocacy - means another group will lose out, even if their case for funding is much stronger

The process by which new, innovative medicines are made available to patients through the health service is broken. It was broken by the Department of Health’s failure to plan ahead for the pipeline of new, reimbursable drugs, and by political meddling that has undermined the credibility of what should be an evidence-based, clinically validated process of priority-setting solely according to health benefit.

Please Subscribe or Log in to continue reading

Subscribe Login

Independent journalism every day

With digital access you can read The Business Post whenever, wherever, and however you want.

  • Unlimited access to all sections of The Business Post on desktop, tablet and mobile.
  • Breaking news, comment and analysis from the best Business Post writers seven days a week.
  • Live blogs of major news events.
  • Videos and podcasts from some of the industry's most respected journalists such as Michael Brennan, Susan Mitchell and Ian Guider.
  • Access to The Business Post's extensive archive​.

Related Articles

More from The Business Post